APA (7th ed.) Citation

Liu, T., Li, S., Xia, C., & Xu, D. (2023). TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance. Frontiers in immunology, 13, 1071390. https://doi.org/10.3389/fimmu.2022.1071390

Chicago Style (17th ed.) Citation

Liu, Tiantian, Shihong Li, Chuanyou Xia, and Dawei Xu. "TERT Promoter Mutations and Methylation for Telomerase Activation in Urothelial Carcinomas: New Mechanistic Insights and Clinical Significance." Frontiers in Immunology 13 (2023): 1071390. https://doi.org/10.3389/fimmu.2022.1071390.

MLA (9th ed.) Citation

Liu, Tiantian, et al. "TERT Promoter Mutations and Methylation for Telomerase Activation in Urothelial Carcinomas: New Mechanistic Insights and Clinical Significance." Frontiers in Immunology, vol. 13, 2023, p. 1071390, https://doi.org/10.3389/fimmu.2022.1071390.